Winners will be announced by email on June 10, 2021
Patients tell about Dr. Christine's side effect approach
MS. DE KONING:
Simple, effective, and fast!"
"My mother was diagnosed with NSCLC in September 2012 and treated with gefitinib. She wanted to stop treatment due to extremely painful nail folds.
Through Christine’s simple, but effective measures, resulting from the TARGET strategy, my mother was able to continue treatment for 5 more years!"
+ Cancer treatments will lead to less symptom burden.
+ You will be able to select appropriate measures that are actually effective for a particular side effect sub-type.
+ Fewer dose adjustments or modifications of cancer therapy than before are needed.
When you choose not to apply the six steps of The Target System on a side effect:
- Side effects will become severe and sustaining
- Patients will be taken off their lifesaving or life-sustaining drug
- This may lead to a decreased outcome.
Mario E. Lacouture, MD
Department of Medicine
Cancer Center (MSKCC),
New York, USA
Joel B. Epstein, DMD
Division of Otolaryngology &
Head & Neck Surgery, City of Hope, Duarte, CA, USA
Antoni van Leeuwenhoek
(AVL) Hospital &
Netherlands Cancer Institute (NKI) Amsterdam, The Netherlands
& Past-president of EONS